Product Code: ETC332669 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Philippines meningococcal vaccines market has shown notable progress, with a CAGR of 5.3%. This growth can be attributed to the government`s emphasis on immunization programs to prevent meningococcal infections. The rise in reported cases of meningococcal disease has also driven vaccine demand.
The Philippines meningococcal vaccines market is primarily driven by government-led vaccination programs aimed at preventing meningococcal infections. The market growth is also supported by rising awareness among the population about the risks associated with meningococcal diseases. Travel-related vaccinations and efforts to curb outbreaks further stimulate the demand for meningococcal vaccines.
The Philippines grapples with challenges in the meningococcal vaccines market, including awareness and affordability. Meningococcal disease awareness remains relatively low compared to other vaccine-preventable illnesses. Overcoming financial barriers and ensuring widespread access to these vaccines is vital to minimizing the impact of meningococcal infections.
The disruptions in healthcare services and the focus on COVID-19 vaccinations have impacted routine immunization programs, including those for meningococcal vaccines. The market has faced challenges in terms of reduced vaccination rates.
Key players in the Philippines meningococcal vaccines market include Pfizer Inc., GlaxoSmithKline plc, Sanofi Pasteur, and Novartis AG.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Meningococcal Vaccines Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Meningococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Meningococcal Vaccines Market - Industry Life Cycle |
3.4 Philippines Meningococcal Vaccines Market - Porter's Five Forces |
3.5 Philippines Meningococcal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Meningococcal Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Philippines Meningococcal Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Meningococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing meningococcal disease |
4.2.2 Government initiatives and campaigns to promote immunization programs |
4.2.3 Rising incidences of meningococcal disease in the Philippines |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas |
4.3.2 High cost of meningococcal vaccines leading to affordability issues |
4.3.3 Lack of public knowledge about meningococcal disease and its prevention |
5 Philippines Meningococcal Vaccines Market Trends |
6 Philippines Meningococcal Vaccines Market, By Types |
6.1 Philippines Meningococcal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Meningococcal Vaccines Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Philippines Meningococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021-2031F |
6.1.4 Philippines Meningococcal Vaccines Market Revenues & Volume, By Conjugate, 2021-2031F |
6.2 Philippines Meningococcal Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Philippines Meningococcal Vaccines Market Revenues & Volume, By Infants, 2021-2031F |
6.2.3 Philippines Meningococcal Vaccines Market Revenues & Volume, By Children, 2021-2031F |
6.2.4 Philippines Meningococcal Vaccines Market Revenues & Volume, By Adolescents & Young Adults, 2021-2031F |
6.2.5 Philippines Meningococcal Vaccines Market Revenues & Volume, By Adults, 2021-2031F |
6.3 Philippines Meningococcal Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Meningococcal Vaccines Market Revenues & Volume, By Pharmacies, 2021-2031F |
6.3.3 Philippines Meningococcal Vaccines Market Revenues & Volume, By Community Clinics, 2021-2031F |
6.3.4 Philippines Meningococcal Vaccines Market Revenues & Volume, By Public Health Agencies, 2021-2031F |
6.3.5 Philippines Meningococcal Vaccines Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Meningococcal Vaccines Market Import-Export Trade Statistics |
7.1 Philippines Meningococcal Vaccines Market Export to Major Countries |
7.2 Philippines Meningococcal Vaccines Market Imports from Major Countries |
8 Philippines Meningococcal Vaccines Market Key Performance Indicators |
8.1 Percentage increase in meningococcal vaccine coverage among the target population |
8.2 Number of government-funded immunization campaigns focused on meningococcal vaccines |
8.3 Rate of reported cases of meningococcal disease in the Philippines |
9 Philippines Meningococcal Vaccines Market - Opportunity Assessment |
9.1 Philippines Meningococcal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Meningococcal Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 Philippines Meningococcal Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Meningococcal Vaccines Market - Competitive Landscape |
10.1 Philippines Meningococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Philippines Meningococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |